 |
Etidronate disodium |
|---|---|
| Trade Name | Didronel |
| Orphan Indication | Hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration |
| USA Market Approval | USA |
| USA Designation Date | 1986-03-21 00:00:00 |
| Sponsor | MGI Pharma, Inc.;5775 West Old Shakopee Rd., Suite 100;Bloomington, Minnesota, 55437 |
